IBDEI1EX ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25049,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25049,1,2,0)
 ;;=2^462.
 ;;^UTILITY(U,$J,358.3,25049,1,5,0)
 ;;=5^PHARYNGITIS,ACUTE
 ;;^UTILITY(U,$J,358.3,25049,2)
 ;;=^2653
 ;;^UTILITY(U,$J,358.3,25050,0)
 ;;=451.2^^144^1558^7
 ;;^UTILITY(U,$J,358.3,25050,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25050,1,2,0)
 ;;=2^451.2
 ;;^UTILITY(U,$J,358.3,25050,1,5,0)
 ;;=5^PHLEBITIS
 ;;^UTILITY(U,$J,358.3,25050,2)
 ;;=^269813
 ;;^UTILITY(U,$J,358.3,25051,0)
 ;;=511.9^^144^1558^8
 ;;^UTILITY(U,$J,358.3,25051,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25051,1,2,0)
 ;;=2^511.9
 ;;^UTILITY(U,$J,358.3,25051,1,5,0)
 ;;=5^PLEURAL EFFUSION NOS
 ;;^UTILITY(U,$J,358.3,25051,2)
 ;;=^123973
 ;;^UTILITY(U,$J,358.3,25052,0)
 ;;=511.0^^144^1558^9
 ;;^UTILITY(U,$J,358.3,25052,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25052,1,2,0)
 ;;=2^511.0
 ;;^UTILITY(U,$J,358.3,25052,1,5,0)
 ;;=5^PLEURISY
 ;;^UTILITY(U,$J,358.3,25052,2)
 ;;=^95432
 ;;^UTILITY(U,$J,358.3,25053,0)
 ;;=486.^^144^1558^10
 ;;^UTILITY(U,$J,358.3,25053,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25053,1,2,0)
 ;;=2^486.
 ;;^UTILITY(U,$J,358.3,25053,1,5,0)
 ;;=5^PNEUMONIA,UNSPEC
 ;;^UTILITY(U,$J,358.3,25053,2)
 ;;=^95632
 ;;^UTILITY(U,$J,358.3,25054,0)
 ;;=698.9^^144^1558^11
 ;;^UTILITY(U,$J,358.3,25054,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25054,1,2,0)
 ;;=2^698.9
 ;;^UTILITY(U,$J,358.3,25054,1,5,0)
 ;;=5^PRURITUS
 ;;^UTILITY(U,$J,358.3,25054,2)
 ;;=^123977
 ;;^UTILITY(U,$J,358.3,25055,0)
 ;;=696.1^^144^1558^12
 ;;^UTILITY(U,$J,358.3,25055,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25055,1,2,0)
 ;;=2^696.1
 ;;^UTILITY(U,$J,358.3,25055,1,5,0)
 ;;=5^PSORIASIS
 ;;^UTILITY(U,$J,358.3,25055,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,25056,0)
 ;;=454.9^^144^1559^1
 ;;^UTILITY(U,$J,358.3,25056,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25056,1,2,0)
 ;;=2^454.9
 ;;^UTILITY(U,$J,358.3,25056,1,5,0)
 ;;=5^VARICOSE VEINS
 ;;^UTILITY(U,$J,358.3,25056,2)
 ;;=^328758
 ;;^UTILITY(U,$J,358.3,25057,0)
 ;;=780.4^^144^1559^2
 ;;^UTILITY(U,$J,358.3,25057,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25057,1,2,0)
 ;;=2^780.4
 ;;^UTILITY(U,$J,358.3,25057,1,5,0)
 ;;=5^VERTIGO
 ;;^UTILITY(U,$J,358.3,25057,2)
 ;;=^35946
 ;;^UTILITY(U,$J,358.3,25058,0)
 ;;=079.99^^144^1559^3
 ;;^UTILITY(U,$J,358.3,25058,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25058,1,2,0)
 ;;=2^079.99
 ;;^UTILITY(U,$J,358.3,25058,1,5,0)
 ;;=5^VIRAL SYNDROME
 ;;^UTILITY(U,$J,358.3,25058,2)
 ;;=^295798
 ;;^UTILITY(U,$J,358.3,25059,0)
 ;;=369.9^^144^1559^4
 ;;^UTILITY(U,$J,358.3,25059,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25059,1,2,0)
 ;;=2^369.9
 ;;^UTILITY(U,$J,358.3,25059,1,5,0)
 ;;=5^VISUAL LOSS (ABN)
 ;;^UTILITY(U,$J,358.3,25059,2)
 ;;=^126769
 ;;^UTILITY(U,$J,358.3,25060,0)
 ;;=780.79^^144^1559^5
 ;;^UTILITY(U,$J,358.3,25060,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25060,1,2,0)
 ;;=2^780.79
 ;;^UTILITY(U,$J,358.3,25060,1,5,0)
 ;;=5^WEAKNESS
 ;;^UTILITY(U,$J,358.3,25060,2)
 ;;=^73344
 ;;^UTILITY(U,$J,358.3,25061,0)
 ;;=783.21^^144^1559^6
 ;;^UTILITY(U,$J,358.3,25061,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25061,1,2,0)
 ;;=2^783.21
 ;;^UTILITY(U,$J,358.3,25061,1,5,0)
 ;;=5^WEIGHT LOSS-ABNORMAL
 ;;^UTILITY(U,$J,358.3,25061,2)
 ;;=^322005
 ;;^UTILITY(U,$J,358.3,25062,0)
 ;;=786.09^^144^1560^10
 ;;^UTILITY(U,$J,358.3,25062,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25062,1,2,0)
 ;;=2^786.09
 ;;^UTILITY(U,$J,358.3,25062,1,5,0)
 ;;=5^SHORTNESS OF BREATH
 ;;^UTILITY(U,$J,358.3,25062,2)
 ;;=^87547
 ;;^UTILITY(U,$J,358.3,25063,0)
 ;;=736.89^^144^1560^1
 ;;^UTILITY(U,$J,358.3,25063,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI1EX
